7 completed, 4 recruiting, 2 active not recruiting, 2 not yet recruiting. 9 Phase 3, 2 Phase 2, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 4, Recruiting 3, Active not recruiting 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow RSVpreF: new trials by email Literature Review of RSVpreF trials Research Report on RSVpreF
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease RSVpreF, Placebo - Respiratory Syncytial Virus (RSV) | Phase 3 | Not yet recruiting | Pfizer | 920 | 2026-09-28 | 2026-09-24 |
| A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults RSVpreF, Placebo - Adult, Healthy Participants | Phase 3 | Recruiting | Pfizer | 600 | 2026-09-09 | 2026-10-09 |
| Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF RSVpreF - RSV Immunization, HIV | Phase 4 | Not yet recruiting | University of British Columbia | 20 | 2026-09-01 | 2026-07-09 |
| A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF RSVpreF, Placebo - Respiratory Syncytial Virus (RSV) | Phase 3 | Recruiting | Pfizer | 540 | 2026-06-22 | 2026-09-24 |
| A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease. RSVpreF - Respiratory Syncytial Virus (RSV) | Phase 3 | Completed | Pfizer | 130 | 2026-05-11 | 2026-09-24 |
| Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy Tdap Vaccine Administration, RSV Vaccine, Saline (as a placebo) - RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 4 | Recruiting | Canadian Immunization Research Network | 60 | 2025-10-16 | 2026-10-22 |
| STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON) ABRYSVO - Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus | Active not recruiting | Pfizer | 1 | 2025-08-11 | 2025-11-19 | |
| A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose RSVpreF, Placebo - RSV Infection | Phase 3 | Recruiting | Pfizer | 550 | 2025-04-16 | 2026-10-14 |
| A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, HZ/su VACCINE - Respiratory Syncytial Virus (RSV) | Phase 3 | Completed | Pfizer | 526 | 2025-04-04 | 2025-11-06 |
| A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). Combination [RSVpreF+BNTb162b2], Bivalent BNT162b2 (original/Omi BA.4/BA.5), RSVpreF - Healthy Participants | Phase 2 | Completed | Pfizer | 1142 | 2023-06-05 | 2024-12-18 |
| A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease RSVpreF, Placebo - RESPIRATORY SYNCYTIAL VIRUS (RSV) | Phase 3 | Completed | Pfizer | 885 | 2023-05-11 | 2025-08-08 |
| A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults RSVpreF+qIRV, qIRV, RSVpreF - Healthy | Phase 1 | Completed | Pfizer | 508 | 2023-03-09 | 2024-11-22 |
| Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. RSVpreF, Placebo - Lower Respiratory Tract Illness | Phase 3 | Active not recruiting | Pfizer | 38861 | 2021-08-31 | 2026-01-28 |
| Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults RSVPreF, Placebo - Respiratory Syncytial Virus Infections | Phase 2 | Completed | Hvivo | 70 | 2020-11-10 | 2024-08-07 |
| A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. RSVpreF, Placebo - Respiratory Tract Infection | Phase 3 | Completed | Pfizer | 14727 | 2020-06-17 | 2025-02-11 |
Influenza, Human (2) · Respiratory Syncytial Virus Infections (2) · COVID-19 (1) · Diphtheria (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Pfizer (12) · Canadian Immunization Research Network (1) · Hvivo (1) · University of British Columbia (1)
United States (8) · Argentina (4) · Japan (4) · Canada (3) · South Africa (3) · Australia (2) · Finland (2) · Netherlands (2) · The Gambia (2) · Brazil (1) · Chile (1) · China (1) · Denmark (1) · India (1) · Mexico (1)
Alex Mann (1) · Bahaa Abu-Raya, M.D., PhD (1) · Golam Kabir, MD (1)
PMID 34774184, PMID 35731653, PMID 37018468, PMID 37018474, PMID 38853036, PMID 39523547, PMID 39733477, PMID 39746206, PMID 39746212, PMID 39928572, PMID 40006705, PMID 40266222, PMID 40872913, PMID 40958705, PMID 41962084
2019 (1)